Your browser doesn't support javascript.
loading
Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres.
Morice, Pierre-Marie; Genthon, Alexis; Boyer, Thomas; Bihan, Kevin; Mahé, Julien; Sourisseau, Anthony; Peyrouzet, Hélène; Miremont, Ghada; Lepelley, Marion; Stefani, Laetitia; Gaboriau, Louise; Rocher, Fanny; Aquaronne, Danièle; Le Beller, Christine; Allouchery, Marion; Azzouz, Brahim; Massy, Nathalie; Alt-Tebacher, Martine; Simand, Célestine; Herbrecht, Raoul; Chrétien, Basile; Dolladille, Charles; Chantepie, Sylvain; Alexandre, Joachim.
Afiliación
  • Morice PM; UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Normandie Univ, Caen, France.
  • Genthon A; Department of Clinical Hematology, Caen University Hospital, Caen, France.
  • Boyer T; Department of Clinical Haematology, Saint Antoine Hospital, Sorbonne University, INSERM UMR-S 938, Paris, France.
  • Bihan K; Laboratory of Hematology, Amiens University Hospital, Amiens, France.
  • Mahé J; Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière University Hospital, Paris, France.
  • Sourisseau A; Regional Pharmacovigilance Center, Department of Clinical Pharmacology, CHU of Nantes, Nantes, France.
  • Peyrouzet H; Departement of Pharmacy, Hotel Dieu University Hospital, Nantes, France.
  • Miremont G; Public Health Unit, Department of Medical Pharmacology, Regional Pharmacovigilance Center, Bordeaux University Hospital, Bordeaux, France.
  • Lepelley M; Public Health Unit, Department of Medical Pharmacology, Regional Pharmacovigilance Center, Bordeaux University Hospital, Bordeaux, France.
  • Stefani L; INSERM, BPH, U1219, Team Pharmacoepidemiology, Univ. Bordeaux, Bordeaux, France.
  • Gaboriau L; Regional Pharmacovigilance Center, Department of Public Health, Grenoble-Alpes University Hospital, Grenobles, France.
  • Rocher F; Department of Medical Oncology, Annecy-Genevois Hospital, Epagny Metz-Tessy, France.
  • Aquaronne D; Regional Pharmacovigilance Center, Department of Pharmacology, Lille University Hospital, Lille, France.
  • Le Beller C; Regional Pharmacovigilance Center, Department of Pharmacology, Cimiez University Hospital, Nice, France.
  • Allouchery M; Laboratory of Hematology, Pasteur University Hospital, Nice, France.
  • Azzouz B; Innovative Therapies in Hemostasis, INSERM, Pharmacovigilance Department, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris University, Paris, France.
  • Massy N; Regional Pharmacovigilance Center, Department of Clinical Pharmacology, Poitiers University, Poitiers University Hospital, Poitiers, France.
  • Alt-Tebacher M; Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, Reims, France.
  • Simand C; EA 3797, Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France.
  • Herbrecht R; Regional Pharmacovigilance Center, Department of Pharmacology, Rouen University Hospital, Rouen, France.
  • Chrétien B; Regional Pharmacovigilance Center, Cardiology Department, Strasbourg University Hospital, Strasbourg, France.
  • Dolladille C; Department of Hematology, Institute for Cancer Strasbourg-Europe (ICANS), Strasbourg University, Strasbourg, France.
  • Chantepie S; Department of Hematology, Institute for Cancer Strasbourg-Europe (ICANS), Strasbourg University, Strasbourg, France.
  • Alexandre J; Regional Pharmacovigilance Center, Department of Pharmacology, Caen University Hospital, Caen, France.
Br J Haematol ; 196(3): 787-793, 2022 02.
Article en En | MEDLINE | ID: mdl-34611896
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Francia